Six presentations demonstrate Galapagos' commitment to the inflammatory bowel disease (IBD) communityNew analyses from Phase 3 SELECTION and SELECTION long-term extension (LTE) studies of Jyseleca® (filgotinib
Investegate announcements from Galapagos NV, Galapagos to present new data from long-term extension study of filgotinib in ulcerative colitis at annual ECCO congress 2023
Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress
2021 OCT 22 By a News Reporter-Staff News Editor at Insurance Daily News New research on Digestive System Diseases and Conditions- Crohn’ s Disease is the subject of a report. Our news journalists obtained a quote from the research from Kitasato University Kitasato Institute Hospital,“ In this study we aim to develop an algorithm for identifying CD using the.